[Results of 2 or 3 secondary drug combinations in the retreatment of chronic pulmonary tuberculosis].
D000293:Adolescent; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003523:Cycloserine / Q000009:adverse effects; D004357:Drug Synergism; D004977:Ethambutol / Q000627:therapeutic use; D005000:Ethionamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D011605:Psychoses, Substance-Induced / Q000209:etiology; D011718:Pyrazinamide / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D003523:Cycloserine; D005000:Ethionamide
Resultados obtenidos mediante regímentes de asociacion con dos o tres drogas secundarias en el retratamiento del tuberculoso pulmonar crónico.